$1.970
-0.113 (-5.74%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
MCRB Prediction & Forecast by Similar Chart Analysis
Alphio's MCRB stock price prediction model matches the current Seres Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.96 (-0.35%). The 1-week path is $1.98 (+0.44%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Seres Therapeutics Inc Stock?
Seres Therapeutics Inc is a good buy right now due to its current price of $1.97, which is significantly lower than its 52-week high of $29.98, indicating substantial upside potential. The forward P/E ratio stands at 10.82, suggesting that the stock is undervalued relative to its future earnings potential. Additionally, the recent positive earnings report showed a net income of $4.6 million for Q2, a turnaround from a loss of $19.9 million in the same quarter last year, which reflects improving financial performance.
MCRB stock price ended at $1.97 on Friday, after losing -5.74%
Seres Therapeutics Inc (MCRB) last closed at $1.97, losing -5.74%. These facts feed the 1-day and 1-week MCRB price prediction above.
Analyst Consensus
Seres Therapeutics Inc (MCRB): 7 buy, 2 hold, 0 sell. Outlook: Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Seres Therapeutics Inc (MCRB) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches MCRB, ranked by similarity.
Seasonality analysis for MCRB
Historically the probability of a positive November return for MCRB is 20.45%. January offers the highest probability of a positive month at 42.62%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.